How Changes in Practice are Changing Bleeding End Points in Coronary Interventional Trials
Cardiac catheterisation and coronary intervention both require catheters to be placed into arteries – engendering risk. In their paper, L.…
Cardiac catheterisation and coronary intervention both require catheters to be placed into arteries – engendering risk. In their paper, L.…
Rare diseases (RDs) are an important public-health issue and a challenge for the medical community. They are called ‘health orphans’,…
Israel has a robust and growing pharmaceutical industry, particularly for biopharmaceuticals and advanced therapeutic medicinal products (ATMP). It is home…
With the growth of mobile devices, healthcare professionals (HCPs) and the general public are accessing and collecting medical information via…
In Russia, most CNS clinical studies have been conducted in MS, epilepsy, AD, stroke, depression and schizophrenia. A number of…
Over the last decade, the only new treatment for Alzheimer’s to make it to market is memantine (Namenda™). The number…
In order to address shortcomings at the discovery stage in oncology studies, PDX has recently emerged as the upcoming technique.…
As the benefits of real-world data become more apparent, so too, do issues around its appropriate collection methodology and reliability.…
When it comes to emerging regions – where sites and monitors generally have less experience in clinical research than those…
The measure of Romania’s success as a clinical trials destination lies in the rapid evolution of the regulatory framework, which…